Why the study?
Does angiotensin II potentiate norepinephrine-induced vasoconstriction in isolated canine mesenteric arteries?
Does angiotensin II potentiate norepinephrine-induced vasoconstriction in isolated canine mesenteric arteries?
Angiotensin II potentiates norepinephrine-induced vasoconstriction in canine mesenteric arteries, likely by modifying intracellular calcium movements and prostaglandin production.
Answers are grounded in this paper and cite their sources.
Supports angiotensin II modulation of vascular tone in canine models; leaves open translation to human physiology or therapy.
Effects of angiotensin II on norepinephrine- and KCl-induced vasoconstrictions were investigated in isolated canine mesenteric arteries which were perfused with Krebs' solution at 37 degrees C. Angiotensin Ii at 0.03-0.3 microgram showed tachyphylaxis in the injection intervals used (10, 20 or 30 min intervals). After treatment with angiotensin II (0.18-1.8 microgram), norepinephrine- and KCl-induced constrictions were consistently potentiated. Imipramine which blocked tyramine-induced action did not significantly influence norepinephrine-induced constriction. pretreatments with both angiotensin II and indomethacin enhanced norepinephrine-induced constriction much greater than that with angiotensin II alone. It is suggested that angiotensin II may modify intracellular Ca movements and prostaglandin production induced by norepinephrine.
No takes yet. Share an insight, caveat, or question.
Chiba et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: